Immunome inc.

Other-Pharmaceuticals

IMNM


Executive/
Director

Price

  • Last Close
  • $ 11.25
    $ +0.74 7.04 %
    Jan 3, 2025
  • 52-Week High/Low
  • $27.34 - $6.35
  • YTD
  • 0%

  • Trading Volume
  • 15,026
  • Market Cap Full
  • $ 480.7M
  • Shares Outstanding
  • 42.7M
    Nov 7, 2023
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Q1 - - - -5% 250% -56.2% 126.8% 130.4% 5.8% -
Q2 - - - 4% -48.9% -43.5% 58.5% -45.9% - -
Q3 - - - 8% 40.8% 38.3% 5.6% -0.3% - -
Q4 - - - -28% -46.8% -50.5% 30.5% -27.1% - -
J F M A M J J A S O N D
2026 - - - - - - - - - - - -
2025 5.8% - - - - - - - - - - -
    2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
    0%0%0%0%0%34%-83%386%-1%6%0%

Earnings

2020 2021 2022 2023
Q1 - -0.37 -0.96 -0.35
Q2 - -0.46 -0.74 -0.46
Q3 - -0.65 -0.75 -0.36
Q4 - -0.66 -0.64 -
A -5.3 -2.1 -3.1 -1.17

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022 2023
Mar - 10.7 12.1 12.2
Jun - 11.8 12.1 12.2
Sep - 11.8 12.1 12.2
Dec 10.5 12.1 12.1 42.7

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage - - -2 - -
Equity multiplier 0.1 - 0.1 0.7 1